Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases

Immunology
0
Pipeline Programs
4
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Teva
TevaIsrael - Petach Tikva
1 program
The Mycophenolate Pregnancy RegistryN/A1 trial
Active Trials
NCT01733082Recruiting500Est. Dec 2026
AT
1 program
The Mycophenolate Pregnancy RegistryN/A
Sandoz
SandozAustria - Kundl
1 program
The Mycophenolate Pregnancy RegistryN/A
Novartis
NovartisBASEL, Switzerland
1 program
The Mycophenolate Pregnancy RegistryN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TevaThe Mycophenolate Pregnancy Registry

Clinical Trials (1)

Total enrollment: 500 patients across 1 trials

NCT01733082TevaThe Mycophenolate Pregnancy Registry

The Mycophenolate Pregnancy Registry

Start: Nov 2012Est. completion: Dec 2026500 patients
N/ARecruiting

Related Jobs in Immunology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 500 patients
4 companies competing in this space